Bee kind: Imperial scientists’ efforts to protect pollinators
Bees are in decline because of intensive farming, pesticide prevalence and climate change – but human welfare depends on them
Bees are in decline because of intensive farming, pesticide prevalence and climate change – but human welfare depends on them
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
Genome editing experts harness the power of CRISPR-Cas enzymes to power the next diagnostic revolution in COVID-19 detection and diagnosis
Find out how to meet tough quality control and assurance regulations with the latest resources, new methods, and exclusive interviews
Explore topics from perfume profiling, salmonella spp. detection, regulatory biopharma compliance, and in situ hybridization
In this series of webinars, discover the latest techniques and technologies helping researchers advance their biopharmaceuticals workflows
Learn how to optimize your biobanking processes for improved biological material quality, security and traceability
Compact design allows placement of stations in laboratory locations where bench space is limited
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics
From DNA extraction kits to pipettes and imaging systems, find out the latest products to join the exclusive ranks of lab equipment most loved by scientists across the world
In this guest article by RayBiotech Life, learn how to easily obtain IHC positive controls for different pathologies without the need for patient samples
The independent study is being led by Southampton University Health Sciences
Improved sample safety and faster plate access for large-capacity microplate incubation applications
Their findings show that Paleocene mammals had more muscular builds than those from the Cretaceous or present day
License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research